A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema
- 1 July 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Retina
- Vol. 28 (7), 919-930
- https://doi.org/10.1097/iae.0b013e31818144a7
Abstract
Purpose: To compare baseline demographic, systemic, and ocular characteristics within age and racial subgroups among participants in this Diabetic Retinopathy Clinical Research Network clinical trial and to compare this cohort with other cohorts enrolled in phase 3 clinical trials for diabetic retinopathy. Methods: Thirty-six month, randomized, controlled, multicenter clinical trial of 693 participants with diabetic macular edema enrolled at 88 clinical sites in the United States. Participants were categorized into self-reported race/ethnicity subgroups and into one of three age groups: 18 to <60, 60 to <70, and 70 and older. Results: Mean age of participants was 63 years, 72% were white, and median visual acuity letter score was 62 (∼20/63). No substantial difference was identified between racial subgroups for any baseline variable. Older participants were more likely to have Type 2 diabetes mellitus and longer duration disease. The most frequent levels of diabetic retinopathy among 840 study eyes were moderate (level 43) to moderately severe (level 47) nonproliferative disease. Conclusion:: While the racial composition of this cohort does not differ from other cohorts in large phase 3 trials that have evaluated participants with diabetic retinopathy, the inclusion of many subjects over age 70 and a better level of glycemic control are distinguishing features.This publication has 19 references indexed in Scilit:
- Retinal Thickness on Stratus Optical Coherence Tomography in People with Diabetes and Minimal or No Diabetic RetinopathyAmerican Journal of Ophthalmology, 2008
- Comparison of the Modified Early Treatment Diabetic Retinopathy Study and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2007
- Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic RetinopathyOphthalmology, 2006
- Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)Diabetologia, 2006
- An Extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) System for Grading of Diabetic Macular Edema in the Astemizole Retinopathy TrialCurrent Eye Research, 2006
- The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: The early treatment diabetic retinopathy follow-up studyOphthalmology, 2003
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The 14-year incidence of visual loss in a diabetic population,Ophthalmology, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993
- Early Treatment Diabetic Retinopathy Study Design and Baseline Patient CharacteristicsOphthalmology, 1991